Health Catalyst enters $225M term loan with Silver Point; $125M drawn to refinance 2025 notes

Health Catalyst, Inc.

Initial term loan of $125M funded July 16, 2024; proceeds to refinance convertible notes due 2025 and for working capital.
Delayed draw facility of $100M (up to $40M within 6 months, $60M within 18 months) for acquisitions.
Interest: SOFR loans at Term SOFR (floor 1%) + 6.50%; base rate loans at ABR (floor 2%) + 5.50%.
Maturity July 16, 2029; quarterly amortization of 0.25% of original principal; prepayment premiums up to 3%+make-whole.
Covenants include minimum liquidity and leverage ratios; collateral secured by substantially all assets.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.